North America Platelet Rich Plasma (prp) Market Size & Outlook
Related Markets
North America platelet rich plasma (prp) market highlights
- The North America platelet rich plasma (prp) market generated a revenue of USD 281.0 million in 2023.
- The market is expected to grow at a CAGR of 13.3% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 281.0 million |
| Market revenue in 2030 | USD 671.9 million |
| Growth rate | 13.3% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, North America region accounted for 43.4% of the global platelet rich plasma (prp) market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 399.9 million by 2030.
Pure prp was the largest segment with a revenue share of 51.6% in 2023. Horizon Databook has segmented the North America platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
The dominance of North America in the global platelet-rich plasma market can be attributed to the increasing number of people suffering from orthopedic disorders and the widening application scope of PRP in therapeutics.
Moreover, increased awareness about PRP treatments, technological advancements, and rising number of cosmetic surgeries are key factors contributing to market growth in the region. The regional presence of several prominent global players further increases North America's revenue share.
Moreover, launching new products can further create lucrative opportunities during the study period. For instance, in June 2023, Dr. PRP USA LLC received FDA 510K clearance for its PRP kits, granting authorization for expanded distribution and application within the medical sector. PRP therapy, acknowledged for enhancing wound healing, utilizes a patient's cells to address and prevent health concerns.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America platelet rich plasma (prp) market size, by country, 2018-2030 (US$M)
North America Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
